IRulya Therapeutics Inc. Common Stock (IRLA) is a publicly traded the market company. As of October 15, 2026, IRLA trades at $29.90 with a market cap of $28.35M and a P/E ratio of 0.00. IRLA moved +0.00% today. Year to date, IRLA is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $25.13 to $32.61. Rallies surfaces IRLA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for IRLA, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $29.90 |
| Market Cap | $28.35M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $32.61 |
| 52-Week Low | $25.13 |
| Volume | 198 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
IRLA analyst coverage data. Average price target: $0.00.